Keyphrases
Intraocular Pressure
100%
Timolol
62%
Glaucoma
48%
Ocular Hypertension
44%
Twice Daily
30%
Optic Nerve
29%
Laser Trabeculoplasty
26%
Argon Laser Trabeculoplasty
26%
Sarcoidosis
26%
Latanoprost
26%
Clinical Trials
26%
Safety Study
26%
Prostaglandin F2α
26%
Outflow Facility
22%
Hypertensive Patients
21%
Isopropyl Esters
19%
Early Glaucoma
17%
Hypertensive
16%
Placebo
15%
Intraocular Pressure Reduction
15%
Dose-response
14%
Glaucomatous
14%
Prostaglandin Analogs
14%
Glaucoma Patients
14%
Pilocarpine
13%
Nursing Mothers
13%
Treatment Variable
13%
Optic Pathway Glioma
13%
Computerized Perimetry
13%
Human Eye
13%
Betaxolol
13%
Asthma
13%
Treatment Protocol
13%
Indentation
13%
Metipranolol
13%
Goldmann Applanation Tonometry
13%
Monotherapy
13%
Topical Timolol
13%
Long-term Efficacy
13%
Dorzolamide
13%
Tonometry
13%
β-adrenergic Antagonist
13%
Multicenter Trial
13%
Interobserver Variability
13%
Optic Nerve Head Imaging
13%
Visual Evoked Potentials
13%
Foveal Vision
13%
Unusual Presentation
13%
United States
13%
Segmentation Analysis
13%
Medicine and Dentistry
Intraocular Pressure
84%
Glaucoma
60%
Optic Nerve
39%
Ocular Hypertension
39%
Trabeculoplasty
26%
Sarcoidosis
26%
Latanoprost
26%
Timolol
23%
Carbonate Dehydratase Inhibitor
17%
Prostaglandin F2
17%
Placebo
15%
Volunteer
15%
Beta Adrenergic Receptor Blocking Agent
15%
Prostaglandin Derivative
14%
Reproducibility
13%
Visual Evoked Potential
13%
Dose Response
13%
Drug Administration
13%
Multiple Drug Dose
13%
Betaxolol
13%
Asthma
13%
Head Imaging
13%
Prospective Study
13%
Metipranolol
13%
Student T Test
13%
Clinical Trial
13%
Contralateral
11%
Drug Therapy
9%
Scanning Electron Microscopy
8%
Group Therapy
7%
Side Effect
6%
Conjunctival Hyperemia
5%
Pulse Rate
5%
Open Angle Glaucoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glaucoma
57%
Timolol
52%
Intraocular Hypertension
43%
Latanoprost
39%
Clinical Trial
26%
Placebo
19%
Carbonate Dehydratase Inhibitor
17%
Prostaglandin F2
17%
Beta Adrenergic Receptor Blocking Agent
15%
Prostaglandin Analogue
14%
Asthma
13%
Metipranolol
13%
Sarcoidosis
13%
Pilocarpine Plus Timolol
13%
Betaxolol
13%
Drug Administration
13%
Corynanthine
13%
Monotherapy
13%
Dorzolamide
13%
Scanning Electron Microscopy
9%
Conjunctival Hyperemia
7%
Side Effect
6%
Disease
6%
Uveitis
6%
Granulomatosis
6%
Adverse Event
6%
Ocular Hypotensive Agent
5%
Add on Therapy
5%
Open Angle Glaucoma
5%